Home » Stocks » Transcat

Transcat, Inc. (TRNS)

Stock Price: $28.60 USD 0.41 (1.45%)
Updated Aug 5, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 212.00M
Revenue (ttm) 169.61M
Net Income (ttm) 8.07M
Shares Out 7.41M
EPS (ttm) 0.96
PE Ratio 29.79
Forward PE 34.97
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 5, 2020
Last Price $28.60
Previous Close $28.19
Change ($) 0.41
Change (%) 1.45%
Day's Open 28.55
Day's Range 26.69 - 28.84
Day's Volume 18,459
52-Week Range 16.50 - 34.18

More Stats

Market Cap 212.00M
Enterprise Value 248.68M
Earnings Date (est) Oct 27, 2020
Ex-Dividend Date n/a
Shares Outstanding 7.41M
Float 6.07M
EPS (basic) 1.1
EPS (diluted) 0.96
FCF / Share 0.71
Dividend n/a
Dividend Yield n/a
Earnings Yield 3.36%
FCF Yield 2.44%
Payout Ratio n/a
Shares Short 69,490
Short Ratio 2.58
Short % of Float 1.06%
Beta 0.68
PE Ratio 29.79
Forward PE 34.97
P/FCF Ratio 41.04
PS Ratio 1.25
PB Ratio 3.15
Revenue 169.61M
Operating Income 10.85M
Net Income 8.07M
Free Cash Flow 5.17M
Net Cash -36.68M
Net Cash / Share -4.95
Gross Margin 25.04%
Operating Margin 6.40%
Profit Margin 4.70%
FCF Margin 3.05%
ROA 5.18%
ROE 11.15%
ROIC 12.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 6
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$34.46*
(20.49% upside)
Low
31.3
Current: $28.60
High
36.0
Target: 34.46
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue17316115514412212411911211091.19
Revenue Growth7.58%3.71%7.81%17.79%-1.18%4.32%5.53%2.07%20.65%-
Gross Profit42.4839.3437.4434.9729.1229.0929.7927.4027.1223.30
Operating Income10.8510.239.037.936.306.776.715.955.434.59
Net Income8.077.155.924.524.124.033.983.703.302.79
Shares Outstanding7.337.207.126.996.896.807.087.407.317.29
Earnings Per Share1.080.950.810.640.580.570.540.490.430.37
EPS Growth13.68%17.28%26.56%10.34%1.75%5.56%10.2%13.95%16.22%-
Operating Cash Flow11.5612.569.877.5410.984.447.615.246.262.57
Capital Expenditures-6.40-6.98-5.87-5.19-4.07-3.45-1.71-2.66-1.39-1.65
Free Cash Flow5.175.584.002.356.910.995.902.584.870.93
Cash & Equivalents0.500.790.580.840.640.070.020.410.030.03
Total Debt37.1821.0022.8527.3119.0712.177.598.023.375.25
Net Cash / Debt-36.68-20.21-22.27-26.47-18.43-12.10-7.57-7.61-3.33-5.22
Assets12810596.8292.1076.7162.1553.8755.0544.9841.36
Liabilities61.0445.6045.4748.7037.8027.8323.7923.4017.6018.03
Book Value67.0959.6351.3543.4038.9134.3230.0831.6527.3823.33
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Transcat, Inc.
Country United States
Employees 722
CEO Lee D. Rudow

Stock Information

Ticker Symbol TRNS
Stock Exchange NASDAQ
Sector Industrials
Industry Industrial Distribution
Unique Identifier NASDAQ: TRNS

Description

Transcat, Inc. provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, oil and gas and alternative energy, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.